Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

PURPOSE: We evaluated the clinical responses and radiographic outcomes of 90 patients with rheumatoid arthritis (RA) undergoing continuous or dose-adjusted infliximab treatment over 104 weeks. PATIENTS AND METHODS: Patients received 3 mg/kg infliximab continuously (the contin group; n=50), or the do...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biologics
Glavni autori: Nozaki, Yuji, Nagare, Yasuaki, Ashida, Chisato, Tomita, Daisuke, Okada, Akinori, Inoue, Asuka, Kinoshita, Koji, Funauchi, Masanori, Matsumura, Itaru
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267494/
https://ncbi.nlm.nih.gov/pubmed/30568425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S187998
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items